Passage Bio
Sarah Monaco is a Scientist II at Passage Bio, where Sarah contributes to the qualification of methods for the release of AAV gene therapies. Prior to their current role, Sarah gained experience as a High Throughput Process Development Scientist at Eurofins PSS Insourcing Solutions and as a Postdoctoral Research Fellow at the Children's Hospital of Philadelphia. Sarah has a background in Neuroscience, holding a PhD from Drexel University and a Master's degree from Drexel University College of Medicine. Sarah is known for their research skills, data analysis, and presentation at scientific conferences.
This person is not in the org chart
Passage Bio
1 followers
Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).